pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,499
stories
Aug 7, 26
BlossomHill, Latigo outshine IPO expectations with oversubscribed debuts
fiercebiotech
Aug 7, 26
Updated: BlossomHill, Latigo cap four-IPO week with combined $496M haul
endpoints
Aug 7, 26
This Week at FDA: Inspection reorg, acting CBER chief eyes IND reforms, and more
raps
Aug 7, 26
EMA issues updated guidance on shortage prevention plans ahead of legal deadline
raps
Aug 6, 26
Replimune rebounds to win FDA approval of melanoma drug
biopharma dive
Aug 6, 26
Third time’s the charm for Replimune as melanoma drug earns FDA greenlight
biospace
Aug 6, 26
STAT+: FDA approves Replimune melanoma drug previously rejected twice
stat
Aug 6, 26
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
fda press
Aug 6, 26
Chutes & Ladders—BioNTech brings in Sobi CEO
fiercebiotech
Aug 6, 26
Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
stat
Aug 6, 26
LifeMine raises $263M in mission to improve organ transplant aftercare
biospace
Aug 6, 26
CROs vs. biotechs: Finding the right fit
biospace
Aug 6, 26
Context scraps bispecific T-cell engager program to extend cash runway deeper into 2027
fiercebiotech
Aug 6, 26
Actimed gets back rights to wasting disease drug, ending $126M deal with Faraday
fiercebiotech
Aug 6, 26
FDA approves Moderna flu vaccine after spat with past agency leaders
endpoints
Aug 6, 26
Revolution Medicines preps for launching pancreatic cancer drug, ups 2026 expenses
endpoints
Aug 6, 26
Cardiac drug developer Braveheart banks more than $382M in IPO
biopharma dive
Aug 5, 26
Lilly confident in slow and steady Foundayo launch, as ex-US sales shine
biospace
Aug 5, 26
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
biopharma dive
Aug 5, 26
No deal between AstraZeneca and BMS, senior source insists: Reuters
biospace
Aug 5, 26
Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad
biospace
Aug 5, 26
Gilead looks to upcoming inflammation, cancer catalysts as pressure to diversify mounts
biospace
Aug 5, 26
STAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and more
stat
Aug 5, 26
Merger talks between AstraZeneca, Bristol Myers are off — report
endpoints
Aug 5, 26
The main therapy used for children with autism faces changes under Medicaid
stat
Aug 5, 26
Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms
biospace
Aug 5, 26
Lilly drops another gene therapy trial from $1B Prevail buyout
fiercebiotech
Aug 5, 26
Opinion: Something is missing from movies about medical aid in dying
stat
Aug 5, 26
MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them
stat
Aug 5, 26
5 NextGen winners who went public this year (and which ones are hiring)
biospace
← prev
page 25 of 50
next →
